US Stock MarketDetailed Quotes

NGNE Neurogene

Watchlist

35.020
-0.600-1.68%

Close Aug 16 16:00 ET

35.020
0.0000.00%

Post 16:09 ET

455.04MMarket Cap-12365P/E (TTM)

Neurogene Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Neurogene Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 0.000	--
--	2024/Q3	-- / 0.000	--
--	2024/Q2	92.000K / 0.000	--
--	2024/Q1	0.000 / 0.000	--
--	2023/Q4	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 0.000--

--2024/Q3-- / 0.000--

--2024/Q292.000K / 0.000--

--2024/Q10.000 / 0.000--

--2023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Neurogene Earnings Reports

Neurogene | 10-Q: Q2 2024 Earnings Report

Aug 9 16:18 ET

Neurogene | 10-Q: Quarterly report

May 10 16:21 ET

Neurogene | 10-K: FY2023 Annual Report

Mar 18 16:06 ET

Neoleukin Therapeutics: Q3 2023 Earnings Report

Nov 14, 2023 08:16 ET

Analyst Rating

Updated: Aug 13, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall